Literature DB >> 30537134

Conference report: pharmacogenomics in special populations at WCP2018.

Guilherme Suarez-Kurtz1, Eleni Aklillu2, Yoshiro Saito3, Andrew A Somogyi4.   

Abstract

The 18th World Congress of Basic and Clinical Pharmacology (WCP2018), coordinated by IUPHAR and hosted by the Japanese Pharmacological Society and the Japanese Society of Clinical Pharmacology and Therapeutics, was held in July 2018 at the Kyoto International Conference Center, in Kyoto, Japan. Having as its main theme 'Pharmacology for the Future: Science, Drug Development and Therapeutics', WCP2018 was attended by over 4500 delegates, representing 78 countries. The present report is an overview of a symposium at WCP2018, entitled Pharmacogenomics in Special Populations, organized by IUPHAR´s Pharmacogenetics/Genomics (PGx) section. The PGx section congregates distinguished scientists from different continents, covering expertise from basic research, to clinical implementation and ethical aspects of PGx, and one of its major activities is the coordination of symposia and workshops to foster exchange of PGx knowledge (https://iuphar.org/sections-subcoms/pharmacogenetics-genomics/). The symposium attracted a large audience to listen to presentations covering various areas of research and clinical adoption of PGx in Oceania, Africa, Latin America and Asia.
© 2018 The British Pharmacological Society.

Entities:  

Keywords:  Africa; Asia; Latin America; Oceania; Pharmacogenomics diversity

Mesh:

Year:  2019        PMID: 30537134      PMCID: PMC6379283          DOI: 10.1111/bcp.13828

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  77 in total

1.  Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia.

Authors:  E U Griese; K F Ilett; N R Kitteringham; M Eichelbaum; H Powell; R M Spargo; P N LeSouef; A W Musk; R F Minchin
Journal:  Pharmacogenetics       Date:  2001-02

2.  SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine.

Authors:  Eleni Aklillu; Abiy Habtewold; Eliford Ngaimisi; Getnet Yimer; Sabina Mugusi; Wondwossen Amogne; Tasmin Reuter; Andreas Meid; Michael Marcus Hoffmann; Johanna Weiss
Journal:  OMICS       Date:  2016-09

Review 3.  H3Africa and the African life sciences ecosystem: building sustainable innovation.

Authors:  Collet Dandara; Farah Huzair; Alexander Borda-Rodriguez; Shadreck Chirikure; Ikechi Okpechi; Louise Warnich; Collen Masimirembwa
Journal:  OMICS       Date:  2014-12

Review 4.  Pharmacogenomic implications of population admixture: Brazil as a model case.

Authors:  Guilherme Suarez-Kurtz; Daniela Polessa Paula; Claudio J Struchiner
Journal:  Pharmacogenomics       Date:  2014-02       Impact factor: 2.533

5.  Conference Report: First Pharmacogenetics and Precision Medicine Conference in Africa (April 7-9, 2016, Cape Town, South Africa).

Authors:  Collet Dandara; Guilherme Suarez-Kurtz; Eleni Aklillu
Journal:  OMICS       Date:  2016-09

6.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

7.  Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients.

Authors:  A Habtewold; W Amogne; E Makonnen; G Yimer; H Nylén; K-D Riedel; G Aderaye; L Bertilsson; J Burhenne; U Diczfalusy; E Aklillu
Journal:  Pharmacogenomics J       Date:  2012-10-23       Impact factor: 3.550

8.  Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study.

Authors:  Tai-Ming Ko; Chang-Youh Tsai; Shih-Yang Chen; Kuo-Shu Chen; Kuang-Hui Yu; Chih-Sheng Chu; Chung-Ming Huang; Chrong-Reen Wang; Chia-Tse Weng; Chia-Li Yu; Song-Chou Hsieh; Jer-Chia Tsai; Wen-Ter Lai; Wen-Chan Tsai; Guang-Dar Yin; Tsan-Teng Ou; Kai-Hung Cheng; Jeng-Hsien Yen; Teh-Ling Liou; Tsung-Hsien Lin; Der-Yuan Chen; Pi-Jung Hsiao; Meng-Yu Weng; Yi-Ming Chen; Chen-Hung Chen; Ming-Fei Liu; Hsueh-Wei Yen; Jia-Jung Lee; Mei-Chuan Kuo; Chen-Ching Wu; Shih-Yuan Hung; Shue-Fen Luo; Ya-Hui Yang; Hui-Ping Chuang; Yi-Chun Chou; Hung-Ting Liao; Chia-Wen Wang; Chun-Lin Huang; Chia-Shuo Chang; Ming-Ta Michael Lee; Pei Chen; Chih-Shung Wong; Chien-Hsiun Chen; Jer-Yuarn Wu; Yuan-Tsong Chen; Chen-Yang Shen
Journal:  BMJ       Date:  2015-09-23

9.  Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations.

Authors:  Eliford Ngaimisi; Abiy Habtewold; Omary Minzi; Eyasu Makonnen; Sabina Mugusi; Wondwossen Amogne; Getnet Yimer; Klaus-Dieter Riedel; Mohammed Janabi; Getachew Aderaye; Ferdinand Mugusi; Leif Bertilsson; Eleni Aklillu; Juergen Burhenne
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

10.  Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.

Authors:  Jackson K Mukonzo; Joel S Owen; Jasper Ogwal-Okeng; Ronald B Kuteesa; Sarah Nanzigu; Nelson Sewankambo; Lehana Thabane; Lars L Gustafsson; Colin Ross; Eleni Aklillu
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more
  2 in total

1.  Implementation and obstacles of pharmacogenetics in clinical practice: An international survey.

Authors:  Elizabeth Abou Diwan; Ralph I Zeitoun; Lea Abou Haidar; Ingolf Cascorbi; Nathalie Khoueiry Zgheib
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

2.  Conference report: pharmacogenomics in special populations at WCP2018.

Authors:  Guilherme Suarez-Kurtz; Eleni Aklillu; Yoshiro Saito; Andrew A Somogyi
Journal:  Br J Clin Pharmacol       Date:  2019-01-24       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.